Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical Model.

Introduction: Health technology assessment of histology-independent therapies (HITs) requires statistical methods that can capture heterogeneity in outcomes while allowing borrowing of information between tumor sites to inform cost-effectiveness analysis. In this study, we extend previous work on bi...

Descripción completa

Detalles Bibliográficos

Publicado en:	Medical Decision Making Vol. 46; no. 5; pp. 637 - 649
Autores principales:	Mikelson, Jan, Birnie, Richard, McCarthy, Grant, Madin-Warburton, Matthew, Xu, Ruifeng, Chumbley, Justin, Aguiar-Ibáñez, Raquel, Amonkar, Mayur, Baio, Gianluca, Young, Kate
Formato:	research tables/charts Journal Article
Publicado:	Sage Publications Inc. Jul2026
Acceso en línea:	Ver este registro en EBSCOhost